Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis

NCT01499355 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01499355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2012
Completion date
December 31, 2015
Enrollment
276 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis